European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Inossia Cement Softener - a new and unique additive to bone cements to revolutionise the treatment of vertebral fractures in osteoporotic patients

Cel

The Inossia Cement Softener is an additive (a softener) for bone cements that lowers their stiffness by 50-75% and adjusts it to that of the bone it is injected into. This does not alter the spinal biomechanics to the extent that the currently used cements do which in turn reduces the risk of new unnecessary vertebral fractures by 75%.
The Inossia Cement Softener has the potential to become a true game-changer and revolutionise the outcome of vertebral augmentation treatments in osteoporotic patients:

the patients will experience immediate pain relief, allowing them to go back to everyday life without the risk of rehospitalization,
the clinicians will be able to offer an efficient treatment
the healthcare payers will save money previously unnecessary spent on the retreatment of already treated patients

Our innovation is designed to revolutionise the treatment of osteoporosis, ensuring a healthy and active ageing.

Koordynator

INOSSIA AB
Wkład UE netto
€ 2 298 325,00
Adres
IOFFICE KUNGSGATAN 64
111 22 Stockholm
Szwecja

Zobacz na mapie

MŚP

Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.

Tak
Region
Östra Sverige Stockholm Stockholms län
Linki
Koszt całkowity
€ 3 283 325,25